Olivier Kretz

1.3k total citations
39 papers, 1.1k citations indexed

About

Olivier Kretz is a scholar working on Molecular Biology, Immunology and Pharmacology. According to data from OpenAlex, Olivier Kretz has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Immunology and 6 papers in Pharmacology. Recurrent topics in Olivier Kretz's work include Toxin Mechanisms and Immunotoxins (8 papers), Herbal Medicine Research Studies (4 papers) and Mass Spectrometry Techniques and Applications (4 papers). Olivier Kretz is often cited by papers focused on Toxin Mechanisms and Immunotoxins (8 papers), Herbal Medicine Research Studies (4 papers) and Mass Spectrometry Techniques and Applications (4 papers). Olivier Kretz collaborates with scholars based in Switzerland, France and Italy. Olivier Kretz's co-authors include Olivier Heudi, Franck Picard, Gerhard Groß, H. Weiss, Samuel Barteau, G. Dirheimer, Kurt Bill, Christian G. Bauer, J. Schmidt and Dieter Zimmer and has published in prestigious journals such as Journal of Clinical Investigation, Analytical Chemistry and Pharmaceutical Research.

In The Last Decade

Olivier Kretz

39 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olivier Kretz Switzerland 20 522 287 156 153 149 39 1.1k
Ziping Yang United States 21 944 1.8× 194 0.7× 315 2.0× 455 3.0× 218 1.5× 45 1.7k
Simon Parry United Kingdom 16 545 1.0× 400 1.4× 120 0.8× 63 0.4× 112 0.8× 29 981
Naiyu Zheng United States 18 336 0.6× 131 0.5× 144 0.9× 127 0.8× 40 0.3× 39 695
Helena Almqvist Sweden 9 902 1.7× 100 0.3× 76 0.5× 225 1.5× 46 0.3× 12 1.3k
Peijuan Zhu United States 16 331 0.6× 154 0.5× 91 0.6× 133 0.9× 52 0.3× 37 776
Marian Kelley United States 14 774 1.5× 910 3.2× 67 0.4× 182 1.2× 555 3.7× 23 1.6k
Sheng Xiong China 22 661 1.3× 158 0.6× 37 0.2× 78 0.5× 111 0.7× 71 1.2k
Henrianna Pang Canada 20 518 1.0× 234 0.8× 82 0.5× 91 0.6× 124 0.8× 26 1.6k
Nathan A. Lack Türkiye 22 668 1.3× 218 0.8× 46 0.3× 169 1.1× 27 0.2× 55 1.4k
John A. Turton United Kingdom 18 491 0.9× 88 0.3× 83 0.5× 112 0.7× 32 0.2× 42 1.1k

Countries citing papers authored by Olivier Kretz

Since Specialization
Citations

This map shows the geographic impact of Olivier Kretz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Kretz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Kretz more than expected).

Fields of papers citing papers by Olivier Kretz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivier Kretz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Kretz. The network helps show where Olivier Kretz may publish in the future.

Co-authorship network of co-authors of Olivier Kretz

This figure shows the co-authorship network connecting the top 25 collaborators of Olivier Kretz. A scholar is included among the top collaborators of Olivier Kretz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivier Kretz. Olivier Kretz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Walles, Markus, Samuel Barteau, Franck Picard, et al.. (2016). The flexibility of a generic LC–MS/MS method for the quantitative analysis of therapeutic proteins based on human immunoglobulin G and related constructs in animal studies. Journal of Pharmaceutical and Biomedical Analysis. 131. 214–222. 7 indexed citations
2.
3.
Heudi, Olivier, Samuel Barteau, Franck Picard, & Olivier Kretz. (2015). Quantitative analysis of maytansinoid (DM1) in human serum by on-line solid phase extraction coupled with liquid chromatography tandem mass spectrometry - Method validation and its application to clinical samples. Journal of Pharmaceutical and Biomedical Analysis. 120. 322–332. 22 indexed citations
4.
Manevski, Nenad, Piet Swart, Kamal K. Balavenkatraman, et al.. (2014). Phase II Metabolism in Human Skin: Skin Explants Show Full Coverage for Glucuronidation, Sulfation, N-Acetylation, Catechol Methylation, and Glutathione Conjugation. Drug Metabolism and Disposition. 43(1). 126–139. 37 indexed citations
5.
Heudi, Olivier, L. Masson, Franck Picard, et al.. (2012). Validation of an on-line solid-phase extraction method coupled to liquid chromatography–tandem mass spectrometry detection for the determination of Indacaterol in human serum. Journal of Chromatography B. 895-896. 1–9. 23 indexed citations
6.
7.
8.
O’Reilly, Terence, Paul M.J. McSheehy, R. Kawai, et al.. (2009). Comparative pharmacokinetics of RAD001 (everolimus) in normal and tumor-bearing rodents. Cancer Chemotherapy and Pharmacology. 65(4). 625–639. 55 indexed citations
9.
Heudi, Olivier, Samuel Barteau, Franck Picard, & Olivier Kretz. (2009). A sensitive LC–MS/MS method for quantification of a nucleoside analog in plasma: Application to in vivo rat pharmacokinetic studies. Journal of Chromatography B. 877(20-21). 1887–1893. 2 indexed citations
10.
Trevaskis, Natalie L., David M. Shackleford, William N. Charman, et al.. (2009). Intestinal Lymphatic Transport Enhances the Post-Prandial Oral Bioavailability of a Novel Cannabinoid Receptor Agonist Via Avoidance of First-Pass Metabolism. Pharmaceutical Research. 26(6). 1486–1495. 42 indexed citations
11.
Takada, Tappei, H. Weiß, Olivier Kretz, Gerhard Groß, & Yuichi Sugiyama. (2004). HEPATIC TRANSPORT OF PKI166, AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR OF THE PYRROLO-PYRIMIDINE CLASS, AND ITS MAIN METABOLITE, ACU154. Drug Metabolism and Disposition. 32(11). 1272–1278. 26 indexed citations
12.
Kretz, Olivier, H. Weiss, M. Schumacher, & Gerhard Groß. (2004). In vitro blood distribution and plasma protein binding of the tyrosine kinase inhibitor imatinib and its active metabolite, CGP74588, in rat, mouse, dog, monkey, healthy humans and patients with acute lymphatic leukaemia. British Journal of Clinical Pharmacology. 58(2). 212–216. 68 indexed citations
13.
Arvidsson, Per I., Neil S. Ryder, H. Weiss, et al.. (2003). Antibiotic and Hemolytic Activity of a β2/β3 Peptide Capable of Folding into a 12/10‐Helical Secondary Structure. ChemBioChem. 4(12). 1345–1347. 98 indexed citations
14.
Kretz, Olivier, et al.. (2002). Coincubation of tissue slices, a new way to study metabolic cooperation between organs: Hepatorenal cooperation in the biotransformation of CGP 47 969 A. Journal of Pharmacological and Toxicological Methods. 48(2). 119–126. 6 indexed citations
15.
Ennamany, R., A Bingen, E.E. Creppy, et al.. (1998). Aspirin® and heparin prevent hepatic blood stasis and thrombosis induced by the toxic glycoprotein Bolesatine in mice. Human & Experimental Toxicology. 17(11). 620–624. 5 indexed citations
16.
Ennamany, R., Olivier Kretz, & E.E. Creppy. (1995). Effect of bolesatine on phospholipid/calcium dependent protein kinase in vero cells and in rat thymus. Archives of Toxicology. 69(9). 624–630. 4 indexed citations
17.
Ennamany, R., Olivier Kretz, Alain Badoc, Gérard Deffieux, & E.E. Creppy. (1994). Effect of bolesatine, a glycoprotein from Boletus satanas, on rat thymus in vivo. Toxicology. 89(2). 113–118. 15 indexed citations
18.
Morini, Maria, et al.. (1993). Mitogenic activity and immunological properties of bolesatine, a lectin isolated from the mushroom Boletus satanas Lenz. International Journal of Biochemistry. 25(5). 789–792. 38 indexed citations
19.
Kretz, Olivier, L Barbieri, E.E. Creppy, & G. Dirheimer. (1992). Inhibition of protein synthesis in liver and kidney of mice by bolesatine: mechanistic approaches to the mode of action at the molecular level. Toxicology. 73(3). 297–304. 12 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ziping Yang Breakdown of academic impact, for papers by Simon Parry Breakdown of academic impact, for papers by Naiyu Zheng Breakdown of academic impact, for papers by Helena Almqvist Breakdown of academic impact, for papers by Peijuan Zhu Breakdown of academic impact, for papers by Marian Kelley Breakdown of academic impact, for papers by Sheng Xiong Breakdown of academic impact, for papers by Henrianna Pang Breakdown of academic impact, for papers by Nathan A. Lack Breakdown of academic impact, for papers by John A. Turton
Rankless by CCL
2026